Virpax acquires rights to Nanomerics' technology to deliver intranasal cannabidiol product Sep. 21, 2021
Celularity and Oncternal collaborate to study placental-derived cellular therapies targeting ROR1 Sep. 21, 2021
NIDA agrees to screen Initiator Pharma's preclinical assets for anti-addictive properties Sep. 20, 2021
Clarus licenses rights to McGill technology to treat conditions associated with CoQ10 deficiencies Sep. 17, 2021
Tarveda and SciClone enter license agreement for preclinical PI3K miniature drug conjugates Sep. 17, 2021
Endeavor BioMedicines licenses rights to ULK1/2 inhibitor for LKB1- and RAS-mutated cancers Sep. 17, 2021
Tempest Therapeutics licenses intellectual property to cancer target from University of California Sep. 14, 2021
USAMRIID to test Navrogen's small-molecule NK cell activators against SARS-CoV-2 infection Sep. 14, 2021
RSS